Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MJR-35 phase 3 study to investigate the efficacy and safety in patients with adenomyosis (a multicenter, randomized, double-blind, placebo-controlled, parallel-group study)

Trial Profile

MJR-35 phase 3 study to investigate the efficacy and safety in patients with adenomyosis (a multicenter, randomized, double-blind, placebo-controlled, parallel-group study)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Sep 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dienogest (Primary)
  • Indications Adenomyosis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Mochida Pharmaceutical
  • Most Recent Events

    • 11 Sep 2017 Primary endpoint (Decrease from baseline in the pain score and visual analogue scale at the end of the treatment) has been met, as per the results published in the Fertility and Sterility.
    • 11 Sep 2017 Results assessing efficacy and safety of dienogest, published in the Fertility and Sterility.
    • 24 Nov 2015 Status changed from not yet recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top